Medpace Clinical Pharmacology

Cincinnati, Ohio 45230

0 studies enrolling now · 15 studies all time

What they study most

Bioequivalence, Bloodstream Infection, Diabetes Mellitus, Type 2, E.Coli Infections, Ethanol Intoxication, Gout, HSV Infection, Healthy Volunteers, Hyperuricemia, Obese But Otherwise Healthy Participants, Obesity, Obesity; Overweight

Studies at this site

Effect of GLP-1 Analogue ROSE-010 on Appetite in Overweight and Obese Subjects — Completed
A 2-part, Phase 1b Clinical Study Designed to Evaluate the Safety, PK, and Efficacy of CRB-913 in Participants With Obesity — Running, not enrolling
Study of BMF-650 in Otherwise Healthy Overweight or Obese Adult Participants — Running, not enrolling
Bioavailability of KBP-5074 Tablet vs Capsule Formulations — Completed
A Clinical Trial to Evaluate the Safety and Efficacy of ADX-629 in in Subjects With Elevated Ethanol Levels — Completed
Potential Influence of Esomeprazole on the Pharmacokinetics of Pritelivir — Completed
A Study Investigating the Safety, Recovery, and Pharmacodynamics of Multiple Oral Administrations of SNIPR001 in Healthy Subjects — Completed
Study to Evaluate and Compare the PK Profiles of Abaloparatide-SC and Abaloparatide-sMTS in a Cohort of Healthy Men and Healthy Women. — Completed
Study to Evaluate and Compare the Bioequivalence of Two Abaloparatide-sMTS Treatments in Healthy Women. — Completed
ALLN-346 Single Ascending Dose (SAD) Study in Healthy Volunteers — Completed
Study 102: Multiple Ascending Dose Study of ALLN-346 (Engineered Urate Oxidase) — Completed
Pharmacodynamic Evaluation of PL2200 Versus Enteric-Coated and Immediate Release Aspirin in Diabetic Patients — Completed
Pharmacodynamic Evaluation of PL2200 Versus Enteric-Coated Aspirin in Diabetic Patients — Completed
Safety and Tolerability Study of Oral LGD-6972 for Type 2 Diabetes Mellitus — Completed
Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LGD-6972 in Healthy Subjects and Subjects With Type 2 Diabetes Mellitus — Completed